Lyell Immunopharma Inc. (LYEL) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
12:04 pm
Purchase
2021-12-3113GLyell Immunopharma, Inc.
LYEL
ARCH Venture Fund IX, L.P.1,820,636
15.100%
1,820,636increase
(New Position)
Filing
History
2022-02-11
3:10 pm
Purchase
2021-12-3113GLyell Immunopharma, Inc.
LYEL
Foresite Capital Fund IV, L.P.664,109
5.500%
664,109increase
(New Position)
Filing
History
2022-02-10
4:51 pm
Purchase
2021-12-3113GLyell Immunopharma, Inc.
LYEL
GSK plc1,512,659
12.600%
1,512,659increase
(New Position)
Filing
History
Goto Prev, 0, 1